Peripheral Nerve Stimulators Market Report 2026

Peripheral Nerve Stimulators Market Overview

• Peripheral Nerve Stimulators market size has reached to $0.76 billion in 2025 • Expected to grow to $1.14 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Rising Prevalence Of Neurological Disorders Fuels Growth In The Peripheral Nerve Stimulators Market • Market Trend: Advancements In Peripheral Nerve Stimulators Focus On Ultra-Miniaturized Systems For Enhanced Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peripheral Nerve Stimulators Market?

Peripheral nerve stimulators refer to medical devices designed to deliver electrical impulses to peripheral nerves in order to manage pain or improve motor function. They are used for treating chronic pain conditions, such as neuropathy, and for aiding in the rehabilitation of patients with nerve injuries or disorders by stimulating nerve activity. The main types of products for peripheral nerve stimulators are transcutaneous, percutaneous, and implantable. Transcutaneous Peripheral Nerve Stimulators (TENS) are non-invasive devices that deliver electrical impulses to the skin to block pain signals or trigger the release of endorphins for pain relief. The multiple devices included are stimulators, continuous peripheral nerve block (CPNB) catheters, pain pumps, and others. The various modes of purchase are disposable and rechargeable devices and are used in several applications, including hospitals, physiotherapy centers, ambulatory surgical centers, clinics, and others.

What Is The Peripheral Nerve Stimulators Market Growth Forecast?

The peripheral nerve stimulators market size is expected to see strong growth in the next few years. It will grow to $1.14 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to advancements in implantable and percutaneous stimulators, increasing adoption of transcutaneous electrical nerve stimulation (tens) units, expansion of ambulatory surgical centers and physiotherapy clinics, rising preference for rechargeable and disposable neurostimulation devices, growing awareness of non-pharmacological pain management solutions. Major trends in the forecast period include increasing adoption of ai-enabled pain management devices, rising use of cloud-based patient monitoring for neurostimulation, growing development of implantable and rechargeable neurostimulators, increasing integration of iot-enabled nerve stimulation systems, rising implementation of smart manufacturing for peripheral nerve stimulators.

Global Peripheral Nerve Stimulators Market Segmentation

1) By Product: Transcutaneous, Percutaneous, Implantable 2) By Device: Stimulators, CPNB Catheters, Pain Pumps, Other Devices 3) By Mode Of Purchase: Disposable Devices, Rechargeable Devices 4) By Application: Hospitals, Physiotherapy Centers, Ambulatory Surgical Centers, Clinics, Other Applications Subsegments: 1) By Transcutaneous: TENS (Transcutaneous Electrical Nerve Stimulation) Units, Surface Electrodes 2) By Percutaneous: Single-Needle Percutaneous Stimulators, Multi-Needle Percutaneous Stimulators, Radiofrequency Percutaneous Stimulators 3) By Implantable: Spinal Cord Stimulators (SCS), Peripheral Nerve Stimulation (PNS) Devices, Neurostimulator Implants

What Is The Driver Of The Peripheral Nerve Stimulators Market?

The increase in the prevalence of neurological disorders is expected to propel the growth of the peripheral nerve stimulators market. Neurological disorders are medical conditions that affect the brain, spinal cord, or peripheral nerves, leading to functional, structural, or biochemical abnormalities. The prevalence of neurological disorders is attributed to factors such as aging populations, genetic predispositions, environmental influences, lifestyle choices, and the increasing awareness and diagnosis of these conditions. Peripheral nerve stimulators play a crucial role in reducing the prevalence of neurological disorders by providing targeted relief from chronic pain, enhancing motor function, and promoting nerve regeneration in affected areas. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to rise to 13.8 million by 2060. Therefore, the increase in the prevalence of neurological disorders is driving the growth of the peripheral nerve stimulators.

Key Players In The Global Peripheral Nerve Stimulators Market

Major companies operating in the peripheral nerve stimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Nevro Corp., Saluda Medical Pty Ltd., Stimwave Technologies Incorporated, Bioness Inc., SPR Therapeutics Inc., Neuspera Medical Inc., NeuroMetrix Inc., BioElectronics Corporation, Soterix Medical Inc., STIM Systems, NeuroSigma Inc., Synapse Biomedical Inc., BioControl Medical, Cardionomic Inc., Aleva Neurotherapeutics SA, NeuroPace Inc., Nervonik Inc., NeuraStim Technologies Inc., NeuroPulse Systems Inc., NeuroStim Devices Inc., Peripheral NeuroSolutions Ltd, BlueWind Medical, PINS Medical, Neurimpulse, Cala Health Inc.

Global Peripheral Nerve Stimulators Market Trends and Insights

Major companies operating in the peripheral nerve stimulators market are focusing on developing innovative products such as ultra-miniaturized systems to enhance patient comfort, improve treatment outcomes, and expand applications in various therapeutic areas. Ultra-miniaturized systems refer to highly compact and small-scale devices designed for advanced functionalities, often leveraging cutting-edge technologies to enhance performance, portability, and integration across various applications. For instance, in April 2023, NeuSpera Medical Inc., a US-based manufacturer of implantable medical devices, announced that it received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system for chronic peripheral nerve pain management. This device is uniquely designed to deliver targeted electrical impulses to peripheral nerves without the use of traditional leads, making it minimally invasive and reducing the risk of complications associated with lead-based devices. Its compact size allows for easy implantation with less tissue disruption, promoting faster recovery times. The micro-implant also offers the potential for long-term pain relief by directly stimulating the affected nerve pathways, providing an advanced solution for patients suffering from chronic peripheral nerve pain.

What Are Latest Mergers And Acquisitions In The Peripheral Nerve Stimulators Market?

In November 2023, Boston Scientific Corporation, a US-based manufacturer of invasive medical devices, acquired Relievant Medsystems Inc. for approximately $850 million. With this acquisition, Boston Scientific aims to enhance its pain management portfolio by incorporating Relievant Medsystems' innovative spinal nerve stimulation technologies. Relievant Medsystems Inc. is a US-based company that develops and commercializes minimally invasive treatments for chronic back pain, specifically targeting vertebrogenic pain.

Regional Outlook

North America was the largest region in the peripheral nerve stimulators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peripheral Nerve Stimulators Market?

The peripheral nerve stimulators market consists of sales of external peripheral nerve stimulators, implantable peripheral nerve stimulators, electrodes for nerve stimulation, and diagnostic stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Peripheral Nerve Stimulators Market Report 2026?

The peripheral nerve stimulators market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral nerve stimulators industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.